![]() |
Trials |
MEK 162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E MutationsCancer type: Solide tumores Phase: I Principal Investigator: Guren Tormod Country: NO Keywords: Norway, Oslo University Hospital Status: Completed Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01352273?term=CMEK162X2102&rank=1 |